{"id":"https://openalex.org/A5048624836","orcid":"https://orcid.org/0000-0002-2625-5728","observed_orcids":["https://orcid.org/0000-0002-2625-5728"],"display_name":"Galateia Liouta","raw_author_names":["Galateia Liouta"],"full_name":"Galateia Liouta","works_count":4,"cited_by_count":79,"summary_stats":{"2yr_mean_citedness":13.0,"h_index":3,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5048624836","orcid":"https://orcid.org/0000-0002-2625-5728","observed_orcids":["https://orcid.org/0000-0002-2625-5728"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210120475","ror":"https://ror.org/02j1xaz06","display_name":"Hospital Agioi Anargyroi","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210120475"]},"years":[2025,2024]},{"institution":{"id":"https://openalex.org/I4210127711","ror":"https://ror.org/033m02g29","display_name":"National Hellenic Research Foundation","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210127711"]},"years":[2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210120475","ror":"https://ror.org/02j1xaz06","display_name":"Hospital Agioi Anargyroi","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210120475"]}],"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","value":1.54e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","value":6.8e-06,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","value":6.6e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9665377736091614},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.6111553311347961},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.5744637846946716},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5278149843215942},{"id":"2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","score":0.451874703168869}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":4},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":14},{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":22},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":39}],"display_name_alternatives":["Galateia Liouta"],"block_key":"g liouta","works_api_url":"https://api.openalex.org/works?filter=author.id:A5048624836","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5048624836","updated_date":"2026-11-12T13:17:38","created_date":"2023-02-04T00:00:00"}